Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2016

01-08-2016 | Breast Oncology

It’s Freezing to Death

Author: V. Suzanne Klimberg, MD

Published in: Annals of Surgical Oncology | Issue 8/2016

Login to get access

Excerpt

Percutaneous treatment of breast cancer was born out of the desire for immediate minimally invasive therapy along with the availability of a variety of emerging ablative tools. Several investigators have published the results of percutaneous ablation using cryoablation, radiofrequency ablation (RFA), laser, high intensity-focused ultrasound (HIFU), and microwave for benign tumors as well as breast cancer followed by confirmatory excision and pathology (reviewed in Ref. 1). Others have attempted percutaneous ablation with careful follow-up and periodic peritumoral bed fine-needle or core biopsy (reviewed in Ref. 1). …
Literature
1.
Klimberg VS, Boneti C, Adkins LL, et al. Feasibility of percutaneous excision followed by ablation for local control in breast cancer. Ann Surg Oncol. 2011;18:3079–87.CrossRefPubMedPubMedCentral
2.
Simmons R, Ballman K, Cox C, Ballman K, Cox C, Carp N et al: A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016. doi:10.​1245/​s10434-016-5275-3.
3.
Klimberg VS, Ochoa D, Henry-Tillman R, et al Long-term results of phase II ablation after breast lumpectomy added to extend intraoperative margins (ABLATE l) trial. J Am Coll Surg. 2014;218:741–9.CrossRefPubMed
4.
5.
Fisher ER, Costantino JP, Leon ME, Bandos H, Palekar AS, Fisher B et al. Pathobiology of small invasive breast cancers without metastases (T1a/b, N0, M0): National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-21. Cancer. 2007;110:1929–36.CrossRefPubMed
Metadata
Title
It’s Freezing to Death
Author
V. Suzanne Klimberg, MD
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 8/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5281-5

Other articles of this Issue 8/2016

Annals of Surgical Oncology 8/2016 Go to the issue

Reconstructive Oncology

Protecting Nipple Perfusion by Devascularization and Surgical Delay in Patients at Risk for Ischemic Complications During Nipple-Sparing Mastectomies

Breast Oncology

Sentinel Lymph Node Biopsy: From B04 to Tumor Genomics

Healthcare Policy and Outcomes

Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes

Breast Oncology

Intraductal Papilloma with Benign Pathology on Breast Core Biopsy: To Excise or Not?

Bone and Soft Tissue Sarcomas

Worse Survival in Elderly Patients with Extremity Soft-Tissue Sarcoma

Gastrointestinal Oncology

Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy